Skip to main content
DNA Labs India

ARFGEF2 Gene Periventricular heterotopia with microcephaly NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

ARFGEF2 Gene Periventricular heterotopia with microcephaly NGS Genetic Test

Short Name: ARFGEF2 PH-M NGS Test

Also known as: ARFGEF2-related periventricular heterotopia test, PH-M ARFGEF2 gene mutation analysis, Periventricular heterotopia microcephaly NGS test

ARFGEF2 Gene Periventricular heterotopia with microcephaly NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks from sample receipt.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

To confirm a clinical or radiological diagnosis of periventricular heterotopia with microcephaly by identifying a pathogenic or likely pathogenic variant in the ARFGEF2 gene using next-generation sequencing. It also assists in evaluating recurrence risk, reproductive counselling, and long-term management planning.

Test Code
4451
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks from sample receipt.
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

No special dietary or fasting preparation is needed. The patient's clinical history, family history and pedigree information should be reviewed during a genetic counselling session before the test.

Method: Peripheral blood draw / FTA card dried blood spot / extracted DNA submission

Step 2

Laboratory Analysis

Depending on the chosen sample type, a small amount of blood will be drawn, or a few drops of blood will be placed on an FTA card. This is a simple and safe procedure.

Step 3

Report Delivery

There are no post-collection restrictions. The sample will be labelled and transported according to genetic testing guidelines. Patients should wait for the report and follow up with their doctor for interpretation.

Timeline: 3 to 4 weeks from sample receipt.

Patient Instructions

1
Before the Test:No special preparation is needed. A pre-test genetic counselling session is recommended to record the family history and draw a pedigree chart.
2
During the Test:A blood sample is collected by a trained professional, or an FTA card blood spot is prepared. The sample is then sent to the laboratory for NGS analysis.
3
After the Test:Patients can resume normal activities immediately after sample collection. Once the report is ready, post-test genetic counselling is advised to explain the results and family implications.

About This Test

Who Should Get This Test

To confirm a clinical or radiological diagnosis of periventricular heterotopia with microcephaly by identifying a pathogenic or likely pathogenic variant in the ARFGEF2 gene using next-generation sequencing. It also assists in evaluating recurrence risk, reproductive counselling, and long-term management planning.

How to Prepare

  • No fasting is required
  • Pre-test genetic counselling session is required
  • Please carry previous medical reports and imaging, if available
  • Free home sample collection can be scheduled when booking online

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This test is valuable not only for confirming a diagnosis but also for informing reproductive decisions. We strongly recommend pre-test and post-test genetic counselling for all families."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs required for the selected collection method (blood/FTA card/extracted DNA)
ContainerEDTA vacutainer (blood), FTA card (dried blood spot), sterile tube (extracted DNA)
Collection MethodPeripheral blood draw / FTA card dried blood spot / extracted DNA submission

Sample Stability

EDTA blood: stable up to 48 hours at 2-8°C
FTA card: stable at ambient room temperature for several days
Extracted DNA: stable at -20°C for long-term storage
Sample Rejection Criteria:
  • Incorrect or missing patient identification
  • Clotted or haemolysed blood sample
  • Insufficient sample quantity
  • Improperly stored or contaminated sample
  • Sample received beyond the recommended time limit

Understanding Your Results

Results should be interpreted by a clinical geneticist in the context of clinical findings, family history and radiological features.
📊

Pathogenic variant detected

Confirms the diagnosis of ARFGEF2-related periventricular heterotopia with microcephaly. Genetic counselling is recommended for the patient and family.

📊

Likely pathogenic variant detected

Variant is highly likely to be disease-causing. Further family testing or clinical correlation may strengthen the interpretation.

📊

Negative / No pathogenic variant detected

No disease-causing variant was identified in the ARFGEF2 gene. Other genetic and non-genetic causes should be considered.

📊

Variant of uncertain significance (VUS) detected

A variant was found, but its clinical significance is not yet known. Additional segregation or functional studies may be required.

⚠️ When to Consult a Doctor:

If you or your child has microcephaly, developmental delay, seizures, abnormal muscle tone, or a family history of periventricular heterotopia with microcephaly, consult a neurologist or clinical geneticist for evaluation and genetic testing.

Limitations

  • This test only analyses the ARFGEF2 gene and does not rule out mutations in other heterotopia or microcephaly genes.
  • Standard NGS may not detect all large deletions, duplications, or complex rearrangements unless specifically included.
  • A variant of uncertain significance (VUS) may require additional family segregation studies.
  • Results should be interpreted in the context of clinical findings and imaging.

Risks & Considerations

  • Minimal discomfort or bruising at the venipuncture site
  • No significant risks associated with FTA card blood spot collection

Interfering Factors

  • Incorrect patient identification or sample labelling
  • Sample contamination or DNA degradation
  • Low quantity or poor quality of extracted DNA
  • Certain deep intronic or large structural variants may not be detected by standard targeted NGS
  • Variants in other genes are not analysed by this single-gene test

Compare With Similar Tests

TestARFGEF2 Gene Periventricular heterotopia with microcephaly NGS Genetic Test
ComparisonARFGEF2 Gene Periventricular heterotopia with microcephaly NGS Genetic Test

Frequently Asked Questions

What is the ARFGEF2 gene periventricular heterotopia with microcephaly NGS genetic test?
It is a targeted next-generation sequencing test that analyses the ARFGEF2 gene to detect disease-causing mutations associated with periventricular heterotopia with microcephaly.
What is the cost of this test?
The test costs Rs 20000 in India. The price includes free home sample collection for online bookings at DNA Labs India.
What type of sample is required?
The sample can be whole blood in an EDTA tube, extracted DNA, or one drop of blood on an FTA card.
Do I need to fast before the test?
No, fasting is not required for this genetic test.
How long does it take to get the report?
The report is usually available within 3 to 4 weeks after the sample reaches the laboratory.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for online bookings across many cities in India.
Who should undergo this test?
Individuals with clinical features of periventricular heterotopia with microcephaly, unexplained microcephaly, seizures, developmental delay, or a family history of ARFGEF2-related disease should consider this test.
Why is genetic counselling necessary before testing?
Genetic counselling helps document clinical and family history, draw a pedigree chart, explain the benefits and limitations of the test, and support informed decision-making.
What does a positive result mean?
A pathogenic or likely pathogenic variant in ARFGEF2 confirms the clinical diagnosis of periventricular heterotopia with microcephaly and allows accurate genetic counselling.
What does a negative result mean?
A negative result means no disease-causing variant was found in the ARFGEF2 gene. It does not exclude other genetic causes of the reported symptoms.
Is this test covered by insurance?
No, this test is generally not covered by insurance and is an out-of-pocket expense for the patient.
Can this test detect all genetic causes of microcephaly?
No, this test only analyses the ARFGEF2 gene. Other genes associated with microcephaly or periventricular heterotopia are not covered by this single-gene NGS test.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.